Mouse models of genetic effects on cognition: Relevance to schizophrenia (Q34183979)

1

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Posterior parietal cortex lesions severely disrupt spatial learning in DBA mice characterized by a genetic hippocampal dysfunction

1 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

1 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology

1 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Modeling madness in mice: one piece at a time

1 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cognition in mouse models of schizophrenia susceptibility genes

1 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning

1 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors

1 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory.

1 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.

1 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex.

1 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

1 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Behavioral characterization of dysbindin-1 deficient sandy mice

1 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic Variation in CACNA1C Affects Brain Circuitries Related to Mental Illness

1 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.

1 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice.

1 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Executive functions in the heterozygous reeler mouse model of schizophrenia.

1 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic variation in DTNBP1 influences general cognitive ability

1 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience.

1 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice

1 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Fear conditioning and latent inhibition in mice lacking the high affinity subclass of nicotinic acetylcholine receptors in the brain

1 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia

1 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Maintenance of superior learning and memory function in NR2B transgenic mice during ageing

1 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Inducible and selective erasure of memories in the mouse brain via chemical-genetic manipulation

1 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impulsive choice induced in rats by lesions of the nucleus accumbens core.

1 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats

1 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA

1 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

1 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Gene-environment interactions in psychiatry: joining forces with neuroscience

1 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Knock-out and knock-in mice to investigate the role of nicotinic receptors in the central nervous system

1 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior

1 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components

1 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior

1 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Differential involvement of prefrontal cortex, striatum, and hippocampus in DRL performance in mice

1 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A behavioural analysis of the delayed non-matching to position task: the effects of scopolamine, lesions of the fornix and of the prelimbic region on mediating behaviours by rats

1 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Behavioral phenotypes of Disc1 missense mutations in mice

1 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor.

1 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Pharmacology and functions of metabotropic glutamate receptors

1 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

1 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal.

1 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background

1 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Glutamate and schizophrenia: beyond the dopamine hypothesis

1 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetics of mouse behavior: interactions with laboratory environment

1 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Behavioral phenotyping strategies for mutant mice

1 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors

1 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues

1 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set.

1 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex.

1 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Requirement of NMDA receptor reactivation for consolidation and storage of nondeclarative taste memory revealed by inducible NR1 knockout

1 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain

1 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Brain-derived neurotrophic factor (BDNF) overexpression in the forebrain results in learning and memory impairments.

1 December 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Case-case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes

1 December 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Comparative immunohistochemical study of the dopaminergic systems in two inbred mouse strains (C57BL/6J and DBA/2J).

1 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Applications of the Morris water maze in the study of learning and memory

1 December 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Molecular activity underlying working memory

1 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice.

1 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Association of HPA axis genes with suicidal behaviour in schizophrenia

1 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia

1 December 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?

1 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic and neurochemical modulation of prefrontal cognitive functions in children.

1 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis

1 December 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Acquisition and extinction of a conditioned passive avoidance reflex in mice with genetic knockout of monoamine oxidase A.

1 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

An overview of the tasks used to test working memory in rodents

1 December 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Rats use a sense of direction to alternate on T-mazes located in adjacent rooms.

1 December 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cognition in transmembrane domain neuregulin 1 mutant mice

1 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli.

1 December 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

1 December 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

1 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions.

1 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Functional organization of the hippocampal memory system

1 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Spatial learning deficit in dopamine D(1) receptor knockout mice

1 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice

1 December 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Prolonged fear responses in mice lacking dopamine D1 receptor

1 December 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Inhibitory autophosphorylation of CaMKII controls PSD association, plasticity, and learning.

1 December 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals

1 December 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear

1 December 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The neuroscience of mammalian associative learning

1 December 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia

1 December 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A review of 25 years of the social interaction test

1 December 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Molecular mechanisms of CaMKII activation in neuronal plasticity

1 December 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia

1 December 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory

1 December 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Mice are not little rats: species differences in a one-day water maze task.

1 December 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior

1 December 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Upregulation of calcium/calmodulin-dependent protein kinase IV improves memory formation and rescues memory loss with aging

1 December 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

How rats perform spatial working memory tasks: Limitations in the use of egocentric and idiothetic working memory

1 December 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice

1 December 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Animal neuropsychology: validation of the Intra-Dimensional Extra-Dimensional set shifting task for mice

1 December 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine

1 December 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks

1 December 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning

1 December 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

1 December 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits

1 December 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia

1 December 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genes and the parsing of cognitive processes

1 December 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Working memory dysfunction in schizophrenia

1 December 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia

1 December 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

GABA transporter-1 activity modulates hippocampal theta oscillation and theta burst stimulation-induced long-term potentiation.

1 December 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Alterations of cortical GABA neurons and network oscillations in schizophrenia.

1 December 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice.

1 December 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dissociable regulation of instrumental action within mouse prefrontal cortex

1 December 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

1 December 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder

1 December 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

1 December 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Increased stress response and β–phenylethylamine in MAOB–deficient mice

1 December 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study

1 December 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma

1 December 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology

1 December 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia.

1 December 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders

1 December 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

1 December 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks

1 December 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.

1 December 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neuronal nicotinic acetylcholine receptors - targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease

1 December 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor

1 December 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories

1 December 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

D4 receptor deficiency in mice has limited effects on impulsivity and novelty seeking

1 December 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder

1 December 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cognitive effects of nicotine: genetic moderators

1 December 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects

1 December 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice.

1 December 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction

1 December 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive

1 December 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Behavioral characterization of dopamine D5 receptor null mutant mice

1 December 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cannabinoid CB1 receptor is dispensable for memory extinction in an appetitively-motivated learning task

1 December 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cognitive impairment in mice over-expressing gamma-aminobutyric acid transporter 1 (GAT1)

1 December 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neurogranin/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling.

1 December 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia

1 December 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory

1 December 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization

1 December 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A decrease of reelin expression as a putative vulnerability factor in schizophrenia

1 December 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice

1 December 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic and dopaminergic modulation of reversal learning in a touchscreen-based operant procedure for mice

1 December 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Specific roles of GABA(B(1)) receptor isoforms in cognition.

1 December 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.

1 December 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Role of dysbindin in dopamine receptor trafficking and cortical GABA function

1 December 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test

1 December 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Decreased c-fos responses to dopamine D(1) receptor agonist stimulation in mice deficient for D(3) receptors

1 December 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors

1 December 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice

1 December 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes.

1 December 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

An important role of neural activity-dependent CaMKIV signaling in the consolidation of long-term memory

1 December 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

1 December 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia.

1 December 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia

1 December 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Phenotypic characterization of transgenic mice overexpressing neuregulin-1

1 December 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

1 December 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Performance of alpha7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task

1 December 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Modeling cognitive endophenotypes of schizophrenia in mice

1 December 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

BDNF regulates eating behavior and locomotor activity in mice

1 December 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Modality-specific retrograde amnesia of fear

1 December 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior.

1 December 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice

1 December 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Assessment of cognitive function in the heterozygous reeler mouse

1 December 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition

1 December 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Olfactory discrimination learning deficit in heterozygous reeler mice

1 December 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modelling of major neurobehavioral syndromes.

1 December 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease

1 December 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Chapter 26 Emotional networks and motor control: a fearful view

1 December 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)

1 December 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice

1 December 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Calcium signaling dysfunction in schizophrenia: a unifying approach

1 December 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Learning deficit in BDNF mutant mice

1 December 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Replication of an association of a common variant in the Reelin gene (RELN) with schizophrenia in Ashkenazi Jewish women

1 December 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task

1 December 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities

1 December 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition

1 December 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Role of dopamine receptors subtypes, D1-like and D2-like, within the nucleus accumbens subregions, core and shell, on memory consolidation in the one-trial inhibitory avoidance task

1 December 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The endogenous cannabinoid system controls extinction of aversive memories

1 December 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impaired passive avoidance learning in mice lacking central neuronal nicotinic acetylcholine receptors

1 December 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Control of memory formation through regulated expression of a CaMKII transgene

1 December 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

1 December 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Mechanisms of fear extinction

1 December 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Spontaneous perseverative turning in rats with radiation-induced hippocampal damage.

1 December 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Disruption of two novel genes by a translocation co-segregating with schizophrenia

1 December 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation

1 December 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Essential role for TrkB receptors in hippocampus-mediated learning

1 December 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor.

1 December 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components

1 December 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Effects of lesions of the orbitofrontal cortex on sensitivity to delayed and probabilistic reinforcement

1 December 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1.

1 December 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Essential role of brain-derived neurotrophic factor in adult hippocampal function

1 December 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Intact spatial learning and memory in transgenic mice with reduced BDNF.

1 December 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Trace and contextual fear conditioning is enhanced in mice lacking the alpha4 subunit of the GABA(A) receptor

1 December 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dysbindin (DTNBP1) and the Biogenesis of Lysosome-Related Organelles Complex 1 (BLOC-1): Main and Epistatic Gene Effects Are Potential Contributors to Schizophrenia Susceptibility

1 December 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms

1 December 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Requirement for hippocampal CA3 NMDA receptors in associative memory recall

1 December 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Handling and environmental enrichment do not rescue learning and memory impairments in alphaCamKII(T286A) mutant mice

1 December 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Glutamate receptor dynamics in dendritic microdomains

1 December 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Strain-dependent differences in LTP and hippocampus-dependent memory in inbred mice

1 December 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk.

1 December 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus

1 December 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility.

1 December 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Enhanced context-dependency of object recognition in rats with hippocampal lesions

1 December 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

1 December 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context

1 December 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice

1 December 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice

1 December 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dysbindin and Schizophrenia: it's dopamine and glutamate all over again

1 December 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice

1 December 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Loss of Ca2+/Calmodulin Kinase Kinase β Affects the Formation of Some, But Not All, Types of Hippocampus-Dependent Long-Term Memory

1 December 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain

1 December 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Presynaptic glutamate receptors: physiological functions and mechanisms of action.

1 December 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia

1 December 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Further developments in the measurement of working memory in rodents

1 December 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice

1 December 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice

1 December 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Enhancement of memory in cannabinoid CB1 receptor knock-out mice.

1 December 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Spatial memory dissociations in mice lacking GluR1.

1 December 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Nicotinic receptors and schizophrenia

1 December 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

1 December 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications

1 December 2024

220

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impaired sequential egocentric and allocentric memories in forebrain-specific-NMDA receptor knock-out mice during a new task dissociating strategies of navigation

1 December 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Epigenetic mechanisms in schizophrenia

1 December 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neural encoding of olfactory recognition memory

1 December 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory

1 December 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model

1 December 2024

225

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The molecular genetics of cognition: dopamine, COMT and BDNF.

1 December 2024

226

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice

1 December 2024

227

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Role of the cholinergic system in the pathology and treatment of schizophrenia.

1 December 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A single dose of methamphetamine leads to a long term reversal of the blunted dopamine D1 receptor-mediated neocortical c-fos responses in mice deficient for D2 and D3 receptors

1 December 2024

229

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A within-subjects, within-task demonstration of intact spatial reference memory and impaired spatial working memory in glutamate receptor-A-deficient mice.

1 December 2024

230

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)).

1 December 2024

231

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families

1 December 2024

232

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.

1 December 2024

233

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A critical role for alpha4betadelta GABAA receptors in shaping learning deficits at puberty in mice

1 December 2024

234

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation

1 December 2024

235

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice

1 December 2024

236

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impaired learning in mice with abnormal short-lived plasticity

1 December 2024

237

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.

1 December 2024

238

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Behavioural assessment of mice lacking D1A dopamine receptors

1 December 2024

239

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dopamine receptor excess and mouse madness

1 December 2024

240

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A genetic variant BDNF polymorphism alters extinction learning in both mouse and human

1 December 2024

241

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Structure and function of declarative and nondeclarative memory systems

1 December 2024

242

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Common variants conferring risk of schizophrenia

1 December 2024

243

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neuregulin 1 and susceptibility to schizophrenia

1 December 2024

244

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

1 December 2024

245

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Comprehensive behavioral analysis of calcium/calmodulin-dependent protein kinase IV knockout mice

1 December 2024

246

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia

1 December 2024

247

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research

1 December 2024

248

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia

1 December 2024

249

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression

1 December 2024

251

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression

1 December 2024

252

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Working memory span capacity improved by a D2 but not D1 receptor family agonist

1 December 2024

254

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor

1 December 2024

255

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females

1 December 2024

256

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory

1 December 2024

257

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Reelin down-regulation in mice and psychosis endophenotypes

1 December 2024

258

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG-saporin-induced lesions on olfactory span performance

1 December 2024

259

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation.

1 December 2024

260

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Reduced attention in mice overproducing corticotropin-releasing hormone

1 December 2024

261

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The environment and schizophrenia

1 December 2024

262

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The brain-derived neurotrophic factor Val66Met polymorphism affects memory formation and retrieval of biologically salient stimuli

1 December 2024

263

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction

1 December 2024

264

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice

1 December 2024

265

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Evaluation of CB1 receptor knockout mice in the Morris water maze

1 December 2024

266

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion

1 December 2024

267

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens.

1 December 2024

268

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks

1 December 2024

269

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia

1 December 2024

271

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease

1 December 2024

272

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders

1 December 2024

273

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Replication of association between working memory and Reelin, a potential modifier gene in schizophrenia

1 December 2024

274

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia

1 December 2024

275

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients

1 December 2024

276

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain

1 December 2024

277

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

A comparison of rats and mice in a swimming pool place task and matching to place task: some surprising differences

1 December 2024

279

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Of mice and mazes: similarities between mice and rats on dry land but not water mazes.

1 December 2024

280

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors

1 December 2024

281

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genomic imprinting effects on brain development and function

1 December 2024

282

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Trace fear conditioning is enhanced in mice lacking the delta subunit of the GABAA receptor

1 December 2024

283

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice.

1 December 2024

284

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Genes, dopamine and cortical signal-to-noise ratio in schizophrenia

1 December 2024

285

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders

1 December 2024

286

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP

1 December 2024

287

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Social transmission of food preference in mice.

1 December 2024

288

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.

1 December 2024

289

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Neuronal Ca2+/calmodulin-dependent protein kinase II--discovery, progress in a quarter of a century, and perspective: implication for learning and memory

1 December 2024

290

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2.

1 December 2024

291

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice

1 December 2024

292

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

The odour span task: a novel paradigm for assessing working memory in mice.

1 December 2024

293

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

1 December 2024

294

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025

Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors

1 December 2024

295

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2011.04.025